Basic HTML Version
www.touchcardiology.com
Interventional Cardiology
Volume 6 • Issue 2 • Extract
Orsiro – The First Hybrid Drug-
eluting Stent, Opening Up a
New Class of Drug-eluting
Stents for Superior Patient
Outcomes
Michael Tittelbach
1
and Tobias
Diener
2
1. Programme Manager for Combination
Products, BIOTRONIK; 2. Head, Product
Development Team, Drug-eluting Stents,
BIOTRONIK